Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

787
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

6.7K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
Same author

iCARDIO Alliance global implementation guidelines for the management of obesity 2025 focus on prevention and treatment of cardiometabolic disease.

American journal of preventive cardiology·2026
Same author

IPTW-based synthetic patients and lab-grown artificial chicken: Scientific feats that must be served with clear labeling.

International journal of cardiology·2026
Same author

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Heart views : the official journal of the Gulf Heart Association·2026
Same author

Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription.

European heart journal·2026
Same author

Cooperative Binding Domains Enhance Sensitivity and Overcome the Hook Effect in Two-Component Protein Biosensors.

ACS sensors·2026

Related Experiment Video

Updated: Apr 30, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

14.2K

Exercise-based rehabilitation for heart failure.

Rod S Taylor1, Viral A Sagar, Ed J Davies

  • 1Institute of Health Research, University of Exeter Medical School, Exeter, UK, EX2 4SG.

The Cochrane Database of Systematic Reviews
|April 29, 2014
PubMed
Summary
This summary is machine-generated.

Exercise-based cardiac rehabilitation for heart failure (HF) reduces hospital admissions and improves quality of life. While short-term mortality shows no change, longer-term exercise may reduce death risk.

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.4K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K

Related Experiment Videos

Last Updated: Apr 30, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

14.2K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.4K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Public Health

Background:

  • Systematic reviews indicate exercise rehabilitation improves heart failure (HF) exercise capacity.
  • Effects on quality of life, mortality, and hospital admissions for HF require further clarification.
  • This review updates a previous Cochrane systematic review from 2010.

Purpose of the Study:

  • To evaluate exercise-based rehabilitation's effectiveness on mortality, hospitalizations, morbidity, and quality of life in HF patients.
  • Expanded inclusion criteria to encompass both HF with reduced ejection fraction (HFREF) and HF with preserved ejection fraction (HFPEF).

Main Methods:

  • Updated systematic search of multiple databases (CENTRAL, MEDLINE, EMBASE, CINAHL, PsycINFO) and trial registers from 2008-2013.
  • Included randomized controlled trials (RCTs) of exercise interventions with ≥6 months follow-up, comparing exercise to usual care.
  • Data extraction and risk of bias assessment were performed independently by two reviewers.

Main Results:

  • 33 trials (4740 participants) included, predominantly HFREF (NYHA classes II-III); 14 new trials identified.
  • No significant difference in all-cause mortality up to 1-year follow-up (RR 0.93; 95% CI 0.69-1.27).
  • Exercise reduced overall (RR 0.75; 95% CI 0.62-0.92) and HF-specific hospitalizations (RR 0.61; 95% CI 0.46-0.80).
  • Significant improvement in health-related quality of life (Minnesota Living with Heart Failure Questionnaire: -5.8 points; 95% CI -9.2 to -2.4).
  • Benefits were consistent across participant characteristics and independent of rehabilitation type or exercise dose.
  • Limited evidence supports exercise for HFPEF and home-based rehabilitation.
  • One study reported increased healthcare costs (USD3227/person); two indicated cost-effectiveness (QALYs, life-years saved).

Conclusions:

  • Exercise-based rehabilitation for HF does not alter short-term mortality but reduces hospital admissions and improves quality of life.
  • Longer-term follow-up suggests a potential reduction in mortality with exercise.
  • Benefits appear consistent across diverse patient demographics and HF severities.
  • Further RCTs are needed to confirm benefits for HFPEF and home-based exercise programs.